News Feb 01, 2008
ProtoKinetix owns the world-wide rights to a family of anti-aging glycoproteins, trademarked as AAGPs™. In clinical tests AAGPs™ have demonstrated the ability to enhance the health and extend the life of biologically sensitive cells which have been subjected to severe stress conditions under laboratory controlled tests. AAGPs™ are stable and non-toxic.
Protein Essential for Making Stem Cells IdentifiedNews
The discovery by Stanford scientists drills a peephole into the black box of cellular reprogramming and may lead to new ways to generate induced pluripotent stem cells in the laboratory.READ MORE
3D Super-Resolution Nanoscopes Used To Identify Amyloid PlaquesNews
A new development in 3D super-resolution imaging gives insight on Alzheimer's diseaseREAD MORE